Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Stotland, J. Kowalski, Belinda Ray (2007)
Patient-Reported Benefit and Satisfaction with Botulinum Toxin Type A Treatment of Moderate to Severe Glabellar Rhytides: Results from a Prospective Open-Label StudyPlastic and Reconstructive Surgery, 120
Terri Gullickson (1995)
Social Research Methods (3rd ed.).Psyccritiques, 40
B. Sommer, I. Zschocke, D. Bergfeld, G. Sattler, M. Augustin (2003)
Satisfaction of Patients After Treatment With Botulinum Toxin for Dynamic Facial LinesDermatologic Surgery, 29
Philippa Lowe, R. Patnaik, N. Lowe (2006)
Comparison of two formulations of botulinum toxin type A for the treatment of glabellar lines: a double-blind, randomized study.Journal of the American Academy of Dermatology, 55 6
J. Comeau, J. Grissett, J. MacLennan (2016)
Social Research Methods
A. Carruthers, J. Carruthers, Joel Cohen (2007)
Dilution volume of botulinum toxin type A for the treatment of glabellar rhytides: does it matter?Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 33 1 Spec No.
A. Carruthers, J. Carruthers, Samireh Said (2005)
Dose‐Ranging Study of Botulinum Toxin Type A in the Treatment of Glabellar Rhytids in FemalesDermatologic Surgery, 31
N. Lowe, B. Ascher, M. Heckmann, C. Kumar, S. Fraczek, Nina Eadie (2005)
Double‐Blind, Randomized, Placebo‐Controlled, Dose‐Response Study of the Safety and Efficacy of Botulinum Toxin Type A in Subjects with Crow's FeetDermatologic Surgery, 31
B. Ascher, B. Rzany, R. Grover (2009)
Efficacy and Safety of Botulinum Toxin Type A in the Treatment of Lateral Crow's Feet: Double‐Blind, Placebo‐Controlled, Dose‐Ranging StudyDermatologic Surgery, 35
S. Ching, A. Thoma, R. McCabe, M. Antony (2003)
Measuring outcomes in aesthetic surgery: a comprehensive review of the literature.Plastic and reconstructive surgery, 111 1
A. Carruthers, Joel Cohen, S. Cox, K. Boulle, S. Fagien, Charles Finn, T. Flynn, N. Lowe, H. Raspaldo, B. Sommer, A. Almeida (2007)
Facial aesthetics: Achieving the natural, relaxed lookJournal of Cosmetic and Laser Therapy, 9
Koen Boulle (2008)
Patient satisfaction with different botulinum toxin type A formulations in the treatment of moderate to severe upper facial rhytidsJournal of Cosmetic and Laser Therapy, 10
J. Carruthers, N. Lowe, M. Menter, J. Gibson, Marian Nordquist, J. Mordaunt, P. Walker, Nina Eadie (2002)
A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines.Journal of the American Academy of Dermatology, 46 6
M. Kane, F. Brandt, Rod Rohrich, R. Narins, G. Monheit, M. Huber (2009)
Evaluation of Variable-Dose Treatment with a New U.S. Botulinum Toxin Type A (Dysport) for Correction of Moderate to Severe Glabellar Lines: Results from a Phase III, Randomized, Double-Blind, Placebo-Controlled StudyPlastic and Reconstructive Surgery, 124
J. Carruthers, A. Carruthers (2007)
Botulinum toxin type A treatment of multiple upper facial sites: patient-reported outcomes.Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 33 1 Spec No.
P. Grimes, Dwana Shabazz (2009)
A Four‐Month Randomized, Double‐Blind Evaluation of the Efficacy of Botulinum Toxin Type A for the Treatment of Glabellar Lines in Women with Skin Types V and VIDermatologic Surgery, 35
The objective of this research was to identify which factors most contributed to patient satisfaction following the treatment of facial lines with botulinum toxin type A. A systematic review was performed by the author, following the Joanna Briggs Institute's methodology, of studies that included data on patient satisfaction following injection of botulinum toxin type A to reduce appearance of facial lines. Seven studies were critically appraised, comprising 696 patients. A relationship between dose, clinical effect and duration of effect was observed, and it was found that lower doses were more likely to result in a decreased duration of action. Patient satisfaction results broadly peaked and declined in line with the timing of the pharmacological effect of botulinum toxin type A. Results suggested patients treated for glabellar lines may be more satisfied in comparison with those treated in the lateral canthus. This review looked at a limited number of parameters that were available for comparison from the current research. The findings have implications for the information patients are given ahead of treatment. More research is needed before adequate comparisons can be made between toxins and dilutions used. The adoption of a standardised assessment tool for botulinum toxin type A and dermal fillers would be useful.
Journal of Aesthetic Nursing – Mark Allen Group
Published: Jul 1, 2012
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.